Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2012-11-14

Clinical Trial Update: A Study to Evaluate Subjects With Turner Syndrome Treated With Growth Hormone

View source ↗

Summary

Completed clinical trial evaluating growth hormone treatment for Turner Syndrome, sponsored by Genentech.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Growth Hormone (somatropin)

Snippet

Sponsor: Genentech, Inc. | Conditions: Turner Syndrome | Status: COMPLETED